Understanding Synaptopodin: The Importance of Studying A Nervous System Protein

Target Name: SYNPO

NCBI ID: G11346

SYNPO

Understanding Synaptopodin: The Importance of Studying A Nervous System Protein

Synaptopodin (ISOform A) is a protein that is expressed in the nervous system and is involved in the transmission of electrical signals from the brain to the rest of the body. It is a member of the tyrosine kinase family and is characterized by its ability to catalyze the transfer of a phosphate group from a tyrosine residue to a protein tyrosine.

Synaptopodin is involved in a number of different processes in the nervous system, including the regulation of neurotransmitter release, the establishment of synaptic plasticity, and the modulation of pain perception. It is also involved in the development and maintenance of the nervous system, as well as in the regulation of sleep and wakefulness.

Despite its importance in many different cellular processes in the nervous system, synaptopodin is not well understood. Only a small number of studies have focused on its role, and much of the existing research on synaptopodin comes from mouse or other animal models.

One of the challenges in studying synaptopodin is its difficulty in purifying and characterizing. Because it is a protein that is expressed in the nervous system, it is difficult to separate and purify from other proteins that are also expressed in the brain. Additionally, the functions of synaptopodin are complex and not fully understood, which can make it difficult to determine the exact mechanism of its action.

Despite these challenges, research on synaptopodin is ongoing and has the potential to shed light on the role of this protein in the nervous system. One potential drug target for synaptopodin is the use of small molecules that can modulate its activity. For example, researchers have shown that inhibitors of the protein tyrosine phosphatase, which is involved in the breakdown of synaptopodin, can increase the levels of synaptopodin in the brain and enhance its activity.

Another potential drug target for synaptopodin is the use of antibodies that can target the protein and enhance its visibility in the brain. This could be useful for studying its localization and distribution in the nervous system, as well as for identifying potential targets for therapeutic intervention.

In addition to its potential as a drug target, synaptopodin is also a potential biomarker for a number of neurological conditions. For example, levels of synaptopodin have been shown to be decreased in the brains of individuals with Alzheimer's disease, and this reduction in synaptopodin has been linked to an increase in the misfolded proteins that are thought to contribute to the development of this disease.

Overall, the study of synaptopodin is an active area of research that has the potential to shed light on the complex role of this protein in the nervous system. Further studies are needed to fully understand its functions and to identify potential drug targets and biomarkers.

Protein Name: Synaptopodin

Functions: Actin-associated protein that may play a role in modulating actin-based shape and motility of dendritic spines and renal podocyte foot processes. Seems to be essential for the formation of spine apparatuses in spines of telencephalic neurons, which is involved in synaptic plasticity (By similarity)

The "SYNPO Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SYNPO comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets